HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

tanezumab

in phase III clinical trials (2010)
Also Known As:
PF 04383119; PF 4383119; PF-04383119; PF-4383119; PF04383119; PF4383119; RI 624; RI-624; RI624 MAb; RN 624; RN-624; RN624 MAb
Networked: 37 relevant articles (18 outcomes, 25 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Brown, Mark T: 14 articles (09/2015 - 10/2010)
2. West, Christine R: 12 articles (09/2015 - 08/2012)
3. Smith, Michael D: 9 articles (09/2015 - 08/2012)
4. Verburg, Kenneth M: 7 articles (09/2015 - 07/2013)
5. Wolfram, Gernot: 4 articles (09/2015 - 09/2013)
6. Bramson, Candace: 4 articles (06/2015 - 10/2011)
7. Spierings, Egilius L H: 3 articles (06/2015 - 09/2013)
8. Keller, David S: 3 articles (11/2014 - 07/2013)
9. Gimbel, Joseph S: 3 articles (11/2014 - 07/2013)
10. Davignon, Isabelle: 3 articles (09/2014 - 08/2012)

Related Diseases

1. Pain (Aches)
2. Osteoarthritis
3. Low Back Pain (Lumbago)
4. Arthralgia (Joint Pain)
5. Neuralgia (Stump Neuralgia)

Related Drugs and Biologics

1. Nerve Growth Factor (NGF)
2. Naproxen (Naprosyn)
3. Opioid Analgesics (Opioids)
4. Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
5. Type A Botulinum Toxins (Botulinum A Toxin)
6. tropisetron (Navoban)
7. Monoclonal Antibodies
8. Oxycodone (Oxycontin)
9. denosumab
10. NAD (NADH)

Related Therapies and Procedures

1. Injections
2. Drug-Eluting Stents
3. Stents
4. Therapeutics
5. Analgesia